After graduating from Oregon Health & Science University with her medical degree, Dr. Rachel Sanborn completed her residency in internal medicine at the University of Illinois at Chicago. Then she returned to Portland for her Fellowship in Hematology and Medical Oncology at Oregon Health & Science University. She is board-certified in medical oncology and internal medicine.
Dr. Sanborn is the Co-Director of the Thoracic Oncology Program, Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute at Providence Cancer Institute. She is also an Institutional Review Board Member for Providence Portland Medical Center. She is a member of several groups, including the American Society of Clinical Oncology, the International Association for the Study of Lung Cancer, Free to Breathe, the Southwest Oncology Group Thoracic Working Group, and the Hoosier Cancer Research Network Thoracic Clinical Trial Working Group.
Oregon Health & Science University 1999
University of Illinois College of Medicine Internal Medicine 2002
Oregon Health & Science University Medical Oncology And Hematology 2005
American Society of Clinical Oncology The International Association for the Study of Lung Cancer Free to Breathe The Southwest Oncology Group Thoracic Working Group The Hoosier Cancer Research Network Thoracic Clinical Trial Working Group
American Board of Internal Medicine, Internal Medicine
Early phase clinical trials open new opportunities
Crizotinib may be a powerful weapon against lung cancer
Providence Portland Medical Center Providence St. Vincent Medical Center Providence Hood River Memorial Hospital Providence Milwaukie Hospital Providence Newberg Medical Center Providence Willamette Falls Medical Center